PureTech Health plc
PTCHF
Price:
$1.7
Market Cap:
$423.70M
PureTech Health plc operates as a clinical-stage biopharmaceutical enterprise, concentrating its efforts in the United States on the discovery, advancement, and market introduction of novel therapeutic solutions. The company's diverse pipeline targets a wide array of challenging medical conditions, including inflammatory, fibrotic, and immunological disorders, intractable cancers, various lymphatic and gastrointestinal issues, as well as neurological and neuropsychological ailments. Among its significant offerings, PureTech provides KarXT, a treatment designed to modulate muscarinic acetylcholine receptors for managing schizophrenia and the psychosis seen in Alzheimer's disease. Its technolo...[Read more]
Industry
Biotechnology
IPO Date
2015-07-29
Stock Exchange
OTC
Ticker
PTCHF
PE Ratio
[-3.70]
ROE
[-31.98%]
Current Ratio
[6.59]
Dividend Yield
[0%]
Enterprise Value
[189.30M]
Dividend History
The ROE as of June 2026 (TTM) for PureTech Health plc (PTCHF) is -31.98%
According to PureTech Health plc’s latest financial reports and current stock price. The company's current ROE is -31.98%. This represents a change of 454.40% compared to the average of -5.77% of the last 4 quarters.
PureTech Health plc (PTCHF) Historical ROE (quarterly & annually)
How has PTCHF ROE performed in the past?
The mean historical ROE of PureTech Health plc over the last ten years is -7.88%. The current -31.98% ROE has changed 305.91% with respect to the historical average. Over the past ten years (40 quarters), PTCHF's ROE was at its highest in in the December 2013 quarter at 170.93%. The ROE was at its lowest in in the June 2013 quarter at -252.67%.
Average
-7.88%
Median
-12.18%
Minimum
-35.89%
Maximum
63.04%
PureTech Health plc (PTCHF) ROE by Quarter and Year
Discovering the peaks and valleys of PureTech Health plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 57.64%
Maximum Annual ROE = 63.04%
Minimum Annual Increase = -1241.79%
Minimum Annual ROE = -35.89%
| Year | ROE | Change |
|---|---|---|
| 2025 | -35.89% | -378.14% |
| 2024 | 12.90% | -191.14% |
| 2023 | -14.16% | 52.44% |
| 2022 | -9.29% | -8.98% |
| 2021 | -10.20% | -1241.79% |
| 2020 | 0.89% | -98.58% |
| 2019 | 63.04% | -345.81% |
| 2018 | -25.65% | -22.26% |
| 2017 | -32.99% | 20.12% |
| 2016 | -27.46% | 57.64% |
PureTech Health plc (PTCHF) Average ROE
How has PTCHF ROE performed in the past?
The current ROE of PureTech Health plc (PTCHF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-12.38%
5-year avg
-11.33%
10-year avg
-7.88%
PureTech Health plc (PTCHF) ROE vs. Peers
How is PTCHF’s ROE compared to its peers?
PureTech Health plc’s ROE is greater than Avacta Group Plc (-2929.47%), greater than Healios K.K. (-75.40%), less than Clinuvel Pharmaceuticals Limited (13.29%), greater than BioInvent International AB (publ) (-53.88%), less than Northwest Biotherapeutics, Inc. (62.41%), less than Clinuvel Pharmaceuticals Limited (13.29%), less than MedinCell S.A. (84.89%), greater than Race Oncology Limited (-47.44%), less than Hua Medicine (Shanghai) Ltd. (107.22%), less than Frontage Holdings Corporation (1.98%),
| Company | ROE | Market cap |
|---|---|---|
| -2929.47% | $454.97M | |
| -75.40% | $193.79M | |
| 13.29% | $348.84M | |
| -53.88% | $216.40M | |
| 62.41% | $312.23M | |
| 13.29% | $307.51M | |
| 84.89% | $1.23B | |
| -47.44% | $451.73M | |
| 107.22% | $338.92M | |
| 1.98% | $223.05M |
Build a custom stock screener for PureTech Health plc (PTCHF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PureTech Health plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
PureTech Health plc (PTCHF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like PureTech Health plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is PureTech Health plc's ROE?
How is the ROE calculated for PureTech Health plc (PTCHF)?
What is the highest ROE for PureTech Health plc (PTCHF)?
What is the 3-year average ROE for PureTech Health plc (PTCHF)?
What is the 5-year average ROE for PureTech Health plc (PTCHF)?
How does the current ROE for PureTech Health plc (PTCHF) compare to its historical average?